Vasoactive intestinal peptide increases intracellular free calcium in rat and human pituitary tumour cells in vitro

in Journal of Endocrinology
Authors:
R. A. Prysor-Jones
Search for other papers by R. A. Prysor-Jones in
Current site
Google Scholar
PubMed
Close
,
J. J. Silverlight
Search for other papers by J. J. Silverlight in
Current site
Google Scholar
PubMed
Close
, and
J. S. Jenkins
Search for other papers by J. S. Jenkins in
Current site
Google Scholar
PubMed
Close
Restricted access
Rent on DeepDyve

Sign up for journal news

ABSTRACT

Prolactin secretion by a human pituitary tumour cell line produced in our laboratory was stimulated by TRH, vasoactive intestinal peptide (VIP) and epithelial growth factor (EGF). All raised the intracellular concentration of free calcium (Ca2+i) of cells loaded with a fluorescent quinoline Ca2+ indicator in suspension, but the effect of TRH was much more rapid and less prolonged than that of VIP and EGF. Both TRH and VIP also increased Ca2+i in GH3 rat pituitary tumour cells, but in this cell line the effect of VIP was only found in attached cells grown on cover-slips. In both human and rat cell lines, the increase in Ca2+i produced by TRH was independent of extracellular calcium, whereas this was a requirement for the action of VIP and EGF. It is concluded that the prolactin secretogogues, VIP and probably EGF, increase Ca2+i through an effect on plasma membrane calcium channels and that this effect differs from that of TRH.

J. Endocr. (1987) 114, 119–123

 

  • Collapse
  • Expand